News | Imaging Software Development | August 29, 2025

HeartFocus Introduces First U.S. Clinical Product on Butterfly Network

FDA-cleared AI-guided cardiac imaging software now available for all U.S healthcare professionals.

HeartFocus Introduces First U.S. Clinical Product on Butterfly Network

Aug. 27, 2025 – HeartFocus, the AI-enabled cardiac imaging software developed by data-driven medtech company DESKi, announced its U.S. commercial launch. HeartFocus will initially be available on Butterfly Network’s handheld ultrasound devices, the FDA-cleared software enables any healthcare professional to conduct diagnostic-quality heart ultrasounds after just hours of training. Health systems, primary care clinics, and clinical education institutions can now access the application. 

Following recent FDA clearance and a successful international clinical trial, HeartFocus has moved from pilot to full deployment, empowering healthcare professionals to conduct fast and comprehensive cardiac assessments anywhere patients are seen, from rural clinics to primary care, education, cardiology, and even in acute high-volume triage environments.

HeartFocus addresses the most persistent barriers in cardiac care: limited access to trained sonographers and long wait times for diagnostic imaging. With just hours of training, any healthcare professional using HeartFocus can capture comprehensive echocardiographic views with consistency that has been clinically proven to match expert operators. Now commercially available through Butterfly Network’s single-probe, whole-body ultrasound system, providing seamless AI integration.

Bertrand Moal, PhD, MD, CEO of DESKi said, “With HeartFocus, we’re unlocking access to life-saving heart scans wherever they’re needed most. This isn’t just a product launch, it represents phase one in our mission to transform how and where cardiac care is delivered, setting a new standard in accessibility and impact.”

Davinder Ramsingh, VP, Innovation Partnerships and Clinical Development at Butterfly Network, said, “This commercial launch marks a first within the Butterfly Garden, offering deep integration with one of the most widely adopted handheld ultrasound systems in the U.S. We’re thrilled to bring HeartFocus to healthcare professionals nationwide. By combining Butterfly’s handheld device with HeartFocus’ AI-powered software, we’re enabling earlier detection and better outcomes, from large health systems to rural, underserved communities.”

Now addressing increasing cardiac care needs, HeartFocus empowers providers of all levels to deliver timely, high-quality cardiac care, anywhere it’s needed.

To learn more, visit www.heartfocus.ai 


Related Content

News | FDA

April 16, 2026 — The U.S. Food and Drug Administration has granted 510(k) clearance to Royal Philips for its Philips ...

Home April 20, 2026
Home
News | FDA

April 7, 2026 —TRiCares SAS has received approval from the U.S. Food and Drug Administration (FDA) for an ...

Home April 09, 2026
Home
News | FDA

April 8, 2026 — Anumana, Inc. recently announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI ...

Home April 08, 2026
Home
News | FDA

March 24, 2026 — Anumana has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary ...

Home March 31, 2026
Home
News | FDA

March 25, 2026 — Royal Philips has received U.S. Food and Drug Administration (FDA) 510(k) clearance for EchoNavigator ...

Home March 27, 2026
Home
News | FDA

March 23, 2026 —Medtronic plc has received U.S. Food and Drug Administration (FDA) approval for an expanded indication ...

Home March 24, 2026
Home
News | FDA

Feb. 27, 2026 — The U.S. Food and Drug Administration (FDA) has approved Abbott’s CardioMEMS Hero device — a pulmonary ...

Home February 27, 2026
Home
News | FDA

Feb. 17, 2026 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Retia Medical's Argos ...

Home February 17, 2026
Home
News | FDA

Jan. 13, 2026 – Innovative Health, Inc. has received its 50th clearance from FDA to reprocess single-use medical devices ...

Home January 15, 2026
Home
News | FDA

Jan. 12, 2026 — HeartLung Corp. has announced U.S. Food and Drug Administration (FDA) clearance of AI-CVD, its AI ...

Home January 12, 2026
Home
Subscribe Now